Immunovia AB (OSTO:IMMNOV)
kr 1.246 0.401 (47.46%) Market Cap: 210.93 Mil Enterprise Value: 182.88 Mil PE Ratio: 0 PB Ratio: 5.77 GF Score: 36/100

Half Year 2020 Immunovia AB (publ) Earnings Call Transcript

Aug 20, 2020 / 02:30PM GMT
Release Date Price: kr87.69 (+0.63%)
Operator

Hello and welcome to Immunovia's Q2 2020 Interim Report. My name is Val, and I will be your coordinator for today's event. Please note, this conference is being recorded. (Operator Instructions)

I will now hand you over to your host, Mats Grahn, CEO of Immunovia, to begin today's conference. Thank you.

Mats Grahn;publ;CEO;Director
Immunovia AB

()-&

Thank you, and welcome to the Immunovia Q2 Report 2020. It's going to be a pleasure today to go through the excellent situation Immunovia is in moving forward towards our market introduction in Q4.

So first about the forward-looking statements. We'll jump right into today's agenda. And today, we will cover, of course, first, the highlights of Q2 and the first half year and the financials. We will then move further into some details on our COVID-19 response, remaining steps to the launch and the status there, and some words about the launch preparation activities. And then we will summarize the target markets of fantastic opportunities that lay

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot